Pradat, Yoann
In the era of extensive data analysis, insights into cancer onset and progression have deepened through molecular analysis of numerous tumors globally. Next-generation sequencing, emerging in the 2000s, transformed cancer cell investigation by enabling exome, transcriptome, and now whole genome profiling. While high-throughput sequencing has not ye...
Borodins, Olegs Broghammer, Felix Seifert, Michael Cordes, Nils
Published in
Computational and Structural Biotechnology Journal
• Preclinical studies support the relevance of adhesion mediated cancer resistance. • Nine cancer types exhibit similar altered expression of adhesion associated genes. • 41 adhesion associated genes show clinical impact on patient survival.
Song, Chengyang Shang, Fangjian Tu, Wei Liu, Xiaodan
Published in
BMC Cancer
Background Disco-interaction protein 2 homologue B (DIP2B) plays an important role in DNA methylation. There have been many reports on DIP2B in various diseases, but neither the diagnostic value nor the prognostic value of DIP2B across cancer types has been deeply explored. Methods The expression levels of DIP2B in 33 cancer types were analysed bas...
Zheng, Xingyu Chen, Lingli Liu, Wenlu Zhao, Shuangshuang Yan, Ye Zhao, Jianzhen Tian, Wenyan Wang, Yingmei
Published in
Hereditas
Background CCNE1 plays an important oncogenic role in several tumors, especially high-stage serous ovarian cancer and endometrial cancer. Nevertheless, the fundamental function of CCNE1 has not been explored in multiple cancers. Therefore, bioinformatics analyses of pan-cancer datasets were carried out to explore how CCNE1 regulates tumorigenesis. ...
Zheng, Zequn Song, Yongfei
Published in
BMC Bioinformatics
KCNH2 encodes the human ether-a-go-go-related gene (hERG) potassium channel and is an important repolarization reserve for regulating cardiac electrical activity. Increasing evidence suggests that it is involved in the development of various tumours, yet a thorough analysis of the underlying process has not been performed. Here, we have comprehensi...
Guo, Kai Tian, Wei Wang, Hongtao Chang, Dongmin Dou, Yawei Yuan, Jinyan Chen, Yaohua Hou, Bin
Published in
BMC medical genomics
Although emerging evidence has revealed that LHPP, a histidine phosphatase protein, suppresses the progression of different cancers, a pan-cancer analysis still remains unavailable. Therefore, we first utilized different bioinformatics tools to explore the tumor inhibitory role of LHPP protein across 33 tumor types based on the TCGA project. Additi...
Xiong, Ye Qi, Yanhua Pan, Ziwen Wang, Shaobo Li, Boyan Feng, Bowen Xue, Hao Zhao, Rongrong Li, Gang
Published in
Cancer cell international
Thymosin family genes (TMSs), biologically important peptides with diverse intracellular and extracellular functions, have been shown to promote the progression of multiple cancers. However, multiomics characterization of TMSs and their role in human cancer prognosis has not been systematically performed. We performed a comprehensive analysis of TM...
Hu, Xinyao Zhu, Hua Chen, Biao He, Xiaoqin Shen, Yang Zhang, Xiaoyu Xu, Yangtao Xu, Ximing
Published in
BMC Cancer
Tubulin alpha-1c chain (TUBA1C), a subtype of α-tubulin, has been shown to be involved in cell proliferation and cell cycle progression in several cancers and to influence cancer development and prognosis. However, a pancancer analysis of TUBA1C to reveal its immunological and prognostic roles has not been performed. In this study, we first downloa...
Zhang, Hanqun Ma, Yan Zhang, Qiuning Liu, Ruifeng Luo, Hongtao Wang, Xiaohu
Published in
BMC Medical Genomics
Background To explore the expression and carcinogenic mechanism of RIPK2 in human tumours, and to provide the theoretical basis for the further study of RIPK2. Methods We used the TCGA, CPTAC, HPA databases to analyse the expression, mutation, and prognosis of RIPK2 in human tumours. Through the Cbioportal, Ualcan, TIMER2.0, and STRING websites, We...
Fäldt Beding, Anna Larsson, Peter Helou, Khalil Einbeigi, Zakaria Parris, Toshima Z.
Published in
BMC Cancer
Background The BIRC5 gene encodes for the Survivin protein, which is a member of the inhibitor of apoptosis family. Survivin is found in humans during fetal development, but generally not in adult cells thereafter. Previous studies have shown that Survivin is abundant in most cancer cells, thereby making it a promising target for anti-cancer drugs ...